Filing Details
- Accession Number:
- 0001628280-24-046462
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-07 19:20:55
- Reporting Period:
- 2024-11-06
- Accepted Time:
- 2024-11-07 19:20:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1706431 | Vir Biotechnology Inc. | VIR | Biological Products, (No Disgnostic Substances) (2836) | 812730369 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2036234 | Vanina Verneuil De | C/O Vir Biotechnology, Inc. 1800 Owens Street, Suite 900 San Francisco CA 94158 | Evp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-06 | 4,397 | $10.11 | 56,973 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2024.
Billionaire Hedge Funds
